利特昔替尼对甲苯磺酸盐
Ritlecitinib Tosylate
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Ritlecitinib Tosylate
CAS2192215-81-7
FormulaC22H27N5O4S
MW457.55
AppearanceWhite to off-white powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

 Ritlecitinib, also known as PF-06651600, is a potent and selective JAK3 inhibitor. PF-06651600 is a potent and low clearance compound with demonstrated in vivo efficacy. The favorable efficacy and safety profile of this JAK3-specific inhibitor PF-06651600 led to its evaluation in several human clinical studies. JAK3 was among the first of the JAKs targeted for therapeutic intervention due to the strong validation provided by human SCID patients displaying JAK3 deficiencies.


Related literature
Related
Sorry, no related items
History
Ritlecitinib Tosylate
Barasertib-HQPA (Synonyms: AZD2811; INH-34; AZD1152-HQPA)
Dydrogesterone EP Impurity A;(9ß,10a)-Pregna-4,6,8(14)-triene-3,20-dione, 9ß,10a-Pregna-4,6,8(14)-triene-3,20-dione, Dydrogesterone Imp. A (EP)
BL-918
Risedronate Sodium | Risedronic Acid Sodium
Resmetirom | MGL-3196 | VIA-3196
Carfilzomib (Synonyms: PR-171)
Teneligliptin hydrobromide ( MP-513 hydrobromide)
Fedratinib | TG-101348 | SAR 302503
Cyclosporin T